Company intelligence / Profile preview

Sim&Cure

Montpellier, Occitanie, Francesim-and-cure.com ↗

Ownership: Private
Employees: ~80
Development stage: Commercial

Overview

Sim&Cure’s CE-marked and FDA-cleared Class IIa medical device software has been used to treat over 5,000 patients in more than 350 hospitals. The platform assists physicians in planning and optimizing endovascular procedures for cerebral aneurysms using digital twin and AI technologies.

Therapeutic areas: Neurology
Modalities: DeviceSoftware
Industry: Digital Health Medical Devices

Partnerships

Scientific and clinical collaborations with leading laboratories and hospitals worldwide

Beyond the preview

Go deeper on Sim&Cure.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sim&Cure.

Explore the full profile